FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study

Introduction: FOLFIRINOX is emerging as new standard of care for fit patients with locally advanced pancreatic cancer (LAPC) and metastatic pancreatic cancer (MPC). However, some of the physicians are reluctant to use FOLFIRINOX due to high toxicity rates reported in earlier studies. We reviewed our...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombouts, SJ, Mungroop, TH, Heilmann, MN, van Laarhoven, HW, Busch, OR, Molenaar, IQ, Besselink, MG, Wilmink, JW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039370/
https://www.ncbi.nlm.nih.gov/pubmed/27698926
http://dx.doi.org/10.7150/jca.16279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039370/
https://www.ncbi.nlm.nih.gov/pubmed/27698926
http://dx.doi.org/10.7150/jca.16279

Ejemplares similares